FinTrust Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $188K | Buy |
1,291
+900
| +230% | +$131K | 0.03% | 319 |
|
|
2024
Q2 | $53.7K | Buy |
391
+18
| +5% | +$2.47K | 0.01% | 512 |
|
|
2024
Q1 | $51.2K | Hold |
373
| – | – | 0.01% | 506 |
|
|
2023
Q4 | $50.7K | Hold |
373
| – | – | 0.01% | 476 |
|
|
2023
Q3 | $45.6K | Sell |
373
-106
| -22% | -$13K | 0.01% | 469 |
|
|
2023
Q2 | $62.9K | Hold |
479
| – | – | 0.02% | 410 |
|
|
2023
Q1 | $62.9K | Hold |
479
| – | – | 0.02% | 411 |
|
|
2022
Q4 | $62.9K | Sell |
479
-18
| -4% | -$2.36K | 0.02% | 412 |
|
|
2022
Q3 | $61K | Buy |
497
+18
| +4% | +$2.21K | 0.02% | 469 |
|
|
2022
Q2 | $59K | Hold |
479
| – | – | 0.01% | 498 |
|
|
2022
Q1 | $63K | Hold |
479
| – | – | 0.01% | 513 |
|
|
2021
Q4 | $73K | Hold |
479
| – | – | 0.02% | 481 |
|
|
2021
Q3 | $77K | Hold |
479
| – | – | 0.02% | 470 |
|
|
2021
Q2 | $78K | Buy |
479
+13
| +3% | +$2.12K | 0.02% | 472 |
|
|
2021
Q1 | $70K | Buy |
466
+93
| +25% | +$14K | 0.02% | 478 |
|
|
2020
Q4 | $57K | Sell |
373
-365
| -49% | -$55.8K | 0.02% | 473 |
|
|
2020
Q3 | $100 | Hold |
738
| – | – | 0.02% | 361 |
|
|
2020
Q2 | $101K | Hold |
738
| – | – | 0.04% | 324 |
|
|
2020
Q1 | $80K | Hold |
738
| – | – | 0.04% | 321 |
|
|
2019
Q4 | $89K | Hold |
738
| – | – | 0.04% | 337 |
|
|
2019
Q3 | $73K | Hold |
738
| – | – | 0.02% | 365 |
|
|
2019
Q2 | $81K | Buy |
738
+465
| +170% | +$51K | 0.03% | 318 |
|
|
2019
Q1 | $31K | Hold |
273
| – | – | 0.01% | 486 |
|
|
2018
Q4 | $26K | Buy |
+273
| New | +$26K | 0.01% | 519 |
|